Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Neurobiol Aging. 2011 Nov 4;33(9):2072–2081. doi: 10.1016/j.neurobiolaging.2011.09.027

Figure 1. GSPE treatment reduces motor deficits in JNPL3 mice.

Figure 1

(A) Body weight in untreated (n=9) and GSPE-treated (n=7) JNPL3 mice following 6 months of treatment. Arrow indicates the initiation of GSPE treatment in JNPL3mice at approximately 9 months of age. Mean values ± SEM. One-way ANOVA showed no significant differences between the groups. (B) Wire hang test assessed in untreated (n=9) and 6-months GSPE treated (n=7) animals at 15 months of age. Results presented as scatter plots and means. GSPE-treatment improved the test scores from 6 sec to 26 sec at p= 0.0368 using one-tailed Mann Whitney t-test for non-parametric data distribution.